KI
PBYI icon

Kapitalo Investimentos’s Puma Biotechnology PBYI Stock Holding History

Kapitalo Investimentos’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-70,269
Closed -$241K – 119
2025
Q2 		$241K Buy
+70,269
New +$224K 0.05% 64

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Kapitalo Investimentos's PBYI Position: Q3 2025 in Review

Kapitalo Investimentos sold out of Puma Biotechnology (PBYI) in Q3 2025, closing a stake of 70,269 shares — an estimated $241K sold.

Kapitalo Investimentos first reported a position in PBYI in Q2 2025 and held it in 1 quarter. The position peaked at $241K in Q2 2025. 132 funds tracked by Wall St. Rank hold PBYI as of Q3 2025.

  • Kapitalo Investimentos reported no remaining Puma Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Kapitalo Investimentos sold 70,269 Puma Biotechnology shares in Q3 2025, an estimated $241K.
  • Kapitalo Investimentos first reported a position in Puma Biotechnology in Q2 2025 and held it in 1 quarter.
  • Kapitalo Investimentos's Puma Biotechnology position peaked at $241K in Q2 2025.
  • 132 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2025.

Based on Kapitalo Investimentos's 13F filing for Q3 2025, filed 3 Nov 2025.